Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

TGF-β in Renal Fibrosis: Triumphs and Challenges
Yue-Yu Gu, Xusheng Liu, Xiao‐Ru Huang, et al.
Future Medicinal Chemistry (2020) Vol. 12, Iss. 9, pp. 853-866
Closed Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

Signaling pathways of chronic kidney diseases, implications for therapeutics
Qian Yuan, Ben Tang, Chun Zhang
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 220
Diosmin ameliorates renal fibrosis through inhibition of inflammation by regulating SIRT3-mediated NF-κB p65 nuclear translocation
Wenman Zhao, Xun-Liang Li, Zhu Yuyu, et al.
BMC Complementary Medicine and Therapies (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 9
Interleukin-1 and Transforming Growth Factor Beta: Commonly Opposing, but Sometimes Supporting, Master Regulators of the Corneal Wound Healing Response to Injury
Steven E. Wilson
Investigative Ophthalmology & Visual Science (2021) Vol. 62, Iss. 4, pp. 8-8
Open Access | Times Cited: 46
Indole-Based Small Molecules as Potential Therapeutic Agents for the Treatment of Fibrosis
Rui Qin, Qian Zhao, Bo Han, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 32
TGF‑β/Smad signaling in chronic kidney disease: Exploring post‑translational regulatory perspectives (Review)
Jianchun Li, Yuanxia Zou, Jiraporn Kantapan, et al.
Molecular Medicine Reports (2024) Vol. 30, Iss. 2
Open Access | Times Cited: 7
Astragalus and its formulas as a therapeutic option for fibrotic diseases: Pharmacology and mechanisms
Yi Zhu, Yilu Chai, Guojin Xiao, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 27
The PI3K-Akt-mTOR pathway mediates renal pericyte-myofibroblast transition by enhancing glycolysis through HKII
Liangmei Chen, Xiaofan Li, Yiyao Deng, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 15
Inflammatory stress in SARS-COV-2 associated Acute Kidney Injury
Junzhe Chen, Wenbiao Wang, Ying Tang, et al.
International Journal of Biological Sciences (2021) Vol. 17, Iss. 6, pp. 1497-1506
Open Access | Times Cited: 30
HDAC6 inhibition: a significant potential regulator and therapeutic option to translate into clinical practice in renal transplantation
Qianqian Zhang, Weijie Zhang, Sheng Chang
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12
Therapeutic potential for renal fibrosis by targeting Smad3-dependent noncoding RNAs
Yue-Yu Gu, Xu‐Sheng Liu, Hui Y. Lan
Molecular Therapy (2023) Vol. 32, Iss. 2, pp. 313-324
Open Access | Times Cited: 12
Plumbagin ameliorates renal fibrosis by suppressing epithelial-mesenchymal transition
H.-S. Kim, Ho‐Geun Yoon, Jung‐Yoon Yoo
Biochemical and Biophysical Research Communications (2025) Vol. 750, pp. 151325-151325
Closed Access
UHRF1 promotes epithelial-mesenchymal transition mediating renal fibrosis by activating the TGF-β/SMAD signaling pathway
Yang Lijie, Penghui Si, Tuoheti Kuerban, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Therapeutic Effects of Quercetin on Renal Fibrosis and Injury
Wenbiao Wang, Wenjing Wu
Integrative Medicine in Nephrology and Andrology (2025) Vol. 12, Iss. 1
Closed Access
Progress of Chinese Medicine in Regulating Altered Lipid Metabolism in Renal Fibrosis
Han Ma, Xiao-Yong Yu
Journal of Contemporary Medical Practice (2025) Vol. 7, Iss. 3, pp. 43-47
Closed Access
Root of Prunus persica (taoshugen) Ameliorated Renal Fibrosis by Inhibiting TGF-β Signaling via Upregulating Pmepa1 in Mice with Unilateral Ureter Obstruction
Wen Long, Xue-Mei Shang, Wenyan Chen, et al.
Journal of Ethnopharmacology (2025), pp. 119750-119750
Closed Access
Long Non-coding RNA: An Emerging Contributor and Potential Therapeutic Target in Renal Fibrosis
Weiping Xia, Yao He, Yu Gan, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 24
Biochanin A Suppresses Klf6-mediated Smad3 Transcription to Attenuate Renal Fibrosis in UUO mice
Yuqing Li, Xinming Yu, Xue-Mei Shang, et al.
Phytomedicine (2024) Vol. 135, pp. 156067-156067
Closed Access | Times Cited: 3
Transforming Growth Factor-β and Long Non-coding RNA in Renal Inflammation and Fibrosis
Yue-Yu Gu, Jing-Yun Dou, Xiao‐Ru Huang, et al.
Frontiers in Physiology (2021) Vol. 12
Open Access | Times Cited: 22
Myeloid-Derived Suppressor Cells Alleviate Renal Fibrosis Progression via Regulation of CCL5-CCR5 Axis
Yue Qiu, Yirui Cao, Guo-Wei Tu, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 21
The Smad3-dependent microRNA let-7i-5p promoted renal fibrosis in mice with unilateral ureteral obstruction
Ze Peng, Huaiying Guo, Yuqing Li, et al.
Frontiers in Physiology (2022) Vol. 13
Open Access | Times Cited: 14
Serum Biomarkers of Renal Fibrosis: A Systematic Review
Alice Barinotti, Massimo Radin, Irene Cecchi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 14139-14139
Open Access | Times Cited: 14
Pioglitazone in diabetic kidney disease: forgotten but not gone
Georgios S. Papaetis
Archives of Medical Science - Atherosclerotic Diseases (2022) Vol. 7, Iss. 1, pp. 78-93
Open Access | Times Cited: 11
G Protein-Coupled Receptor Kinase 2 as Novel Therapeutic Target in Fibrotic Diseases
Nan Li, Shan Shan, Xiuqin Li, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 10
Gypenosides suppress fibrosis of the renal NRK-49F cells by targeting miR-378a-5p through the PI3K/AKT signaling pathway
Lan Zhang, Xiting Wang, Shuangshuang He, et al.
Journal of Ethnopharmacology (2023) Vol. 311, pp. 116466-116466
Closed Access | Times Cited: 6
Isoliensinine Attenuates Renal Fibrosis and Inhibits TGF-β1/Smad2/3 Signaling Pathway in Spontaneously Hypertensive Rats
Mengying Yao, Dawei Lian, Meizhu Wu, et al.
Drug Design Development and Therapy (2023) Vol. Volume 17, pp. 2749-2762
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top